Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
Background: Faecal microbiota transplantation (FMT) is an effective treatment of recurrent Clostridioides difficile infection (rCDI) and is being applied experimentally in other diseases. Encapsulated administration may be equivalent in efficacy to delivery through other routes. Methods: A systemati...
Main Authors: | Frederik Cold, Simon Mark Dahl Baunwall, Jens Frederik Dahlerup, Andreas Munk Petersen, Christian Lodberg Hvas, Lars Hestbjerg Hansen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-08-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848211041004 |
Similar Items
-
Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection
by: Shaodong Wei, et al.
Published: (2022-12-01) -
Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections
by: Anne Karmisholt Grosen, et al.
Published: (2019-08-01) -
Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent <i>Clostridioides difficile</i> Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
by: Frederik Cold, et al.
Published: (2022-01-01) -
Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review
by: Lianna Hede Hammeken, et al.
Published: (2021-01-01) -
The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study
by: Camilla Kara Svensson, et al.
Published: (2022-10-01)